ABEOAbeona Therapeutics Inc.

ABEO Stock Price, Valuation & Chart | Abeona Therapeutics Inc.

Compare

$5.950-0.03 (-0.50%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ABEO intrinsic value ABEO calculated fair value vs price

Overview Financials Dividends Ratios

ABEO Historical price chart

ABEO Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization339.12M

PE Ratio-5.46

EPS-1.09

Trading Volume1.08M

Today's High/Low6.1/5.86

Dividend Yield0.00

52 Week High/Low7.65/4.0

Shares Outstanding57.00M

ABEO Financial Statement

ABEO Analyst ratings

ABEO Analysis & performance metrics

ABEO Company profile

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101,…

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy…

ABEO Management team

Name

Position

Joseph Walter Vazzano CPACFO

Chief Financial Officer

Brendan M. O'Malley J.D., Ph.D.

Chief Legal Officer

Jon Voss

Vice President & Head of Quality

Madhav Vasanthavada M.B.A., Ph.D.

Senior Vice President, Chief Commercial Officer & Head of Business Development

Carl Denny

Senior Vice President of Regulatory Affairs

Alison Hardgrove

Chief People Officer

Gregory Gin

Vice President of Investor Relations & Corporate Communications

Vishwas Seshadri M.B.A., Ph.D.CEO

President, Chief Executive Officer & Director

Name

Position

Joseph Walter Vazzano CPACFO

Chief Financial Officer

Brendan M. O'Malley J.D., Ph.D.

Chief Legal Officer

Jon Voss

Vice President & Head of Quality

Madhav Vasanthavada M.B.A., Ph.D.

Senior Vice President, Chief Commercial Officer & Head of Business Development

Carl Denny

Senior Vice President of Regulatory Affairs

Alison Hardgrove

Chief People Officer

Gregory Gin

Vice President of Investor Relations & Corporate Communications

Vishwas Seshadri M.B.A., Ph.D.CEO

President, Chief Executive Officer & Director

Management Team

Joseph Walter Vazzano CPACFO

Chief Financial Officer

Brendan M. O'Malley J.D., Ph.D.

Chief Legal Officer

Jon Voss

Vice President & Head of Quality

Madhav Vasanthavada M.B.A., Ph.D.

Senior Vice President, Chief Commercial Officer & Head of Business Development

Carl Denny

Senior Vice President of Regulatory Affairs

Alison Hardgrove

Chief People Officer

Gregory Gin

Vice President of Investor Relations & Corporate Communications

Vishwas Seshadri M.B.A., Ph.D.CEO

President, Chief Executive Officer & Director

Management

Joseph Walter Vazzano CPACFO

Chief Financial Officer

Brendan M. O'Malley J.D., Ph.D.

Chief Legal Officer

Jon Voss

Vice President & Head of Quality

Madhav Vasanthavada M.B.A., Ph.D.

Senior Vice President, Chief Commercial Officer & Head of Business Development

Carl Denny

Senior Vice President of Regulatory Affairs

Alison Hardgrove

Chief People Officer

Gregory Gin

Vice President of Investor Relations & Corporate Communications

Vishwas Seshadri M.B.A., Ph.D.CEO

President, Chief Executive Officer & Director

Total 8 executives

ABEO Frequently asked questions

What is Abeona Therapeutics Inc. (ABEO) Stock Price?

Current stock price of Abeona Therapeutics Inc. (ABEO) stock is $5.950. The stock price is -0.50% lower in the session. The intraday range can be seen from this page. Volume of Abeona Therapeutics Inc. (ABEO) stock is 1.08M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Abeona Therapeutics Inc. (ABEO) stock price going up or down today?

The stock price of Abeona Therapeutics Inc. (ABEO) can change with earnings, company news, and overall market sentiment. Abeona Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Abeona Therapeutics Inc. stock expensive at its current price?

Whether Abeona Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ABEO on this page is -5.46. EPS on this page is -1.09. Compare those figures with peers and growth expectations before deciding if the current Abeona Therapeutics Inc. price is justified.

How has the stock price of Abeona Therapeutics Inc. (ABEO) performed historically?

Historical performance for Abeona Therapeutics Inc. (ABEO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ABEO reacted to past earnings and market events.

Should I buy Abeona Therapeutics Inc. (ABEO) stock, at this price?

Buying Abeona Therapeutics Inc. (ABEO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.